Pharma Industry News

UK study highlights potential of genetic screening for prostate cancer

Genetic ‘barcoding’ in GP surgeries can identify men at higher risk of prostate cancer, researchers claimOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]